Table 2

Cancer research investment awards and funding by cross-cutting theme

Cross-cutting themeAll funders where investment data were availableCancer Research UK
Number of awardsPercentage of totalSum investment (£)Percentage of totalMean award, £ (SD)Median award, £ (IQR)Number of awardsPercentage of all oncology research awards
Pathogenesis (mechanism)2275.3%£1 374 387 83857.6%543 881 (955 710)248 573 (135 752–506 232)167451.0%
Drug therapy110425.7%£620 961 06026.0%562 464 (1 910 050)202 342 (105 622–436 559)93528.5%
Diagnostic, screening and monitoring68115.8%£359 618 82315.1%528 074 (1 155 156)205 728 (102 672–513 836)40412.3%
Women's health64014.9%£199 534 6938.4%311 773 (1 041 520)153 845 (56 515–227 202)2878.7%
Immunology (biologics)45110.5%£194 086 6178.1%430 347 (760 955)240 052 (125 669–466 250)2126.5%
Radiotherapy1122.6%£88 262 3533.7%788 056 (2 413 445)243 333 (106 175–439 419)2096.4%
Psychosocial1172.7%£23 445 8351.0%200 391 (352 410)87 463 (27 317–239 059)1223.7%
Men's health1112.6%£143 392 9086.0%1 291 828 (5 617 919)285 203 (126 037–700 353)1203.7%
Paediatrics1754.1%£62 641 9382.6%357 953 (547 484)183 099 (89 522–322 261)1183.6%
Surgery721.7%£37 900 3341.6%526 393 (684 908)235 413 (97 890–761 651)952.9%
Infection associated1293.0%£56 819 3792.4%440 460 (798 013)231 836 (134 693–439 378)481.5%
Global health120.3%£6 434 9600.3%536 246 (1 089 118)129 738 (77 519–459 274)120.4%
Geriatrics70.2%£1 616 3940.1%230 913 (254 925)121 623 (76 421–262 167)80.2%
Occupational health180.4%£2 576 8410.1%143 157 (116 928)137 103 (33 857–199 998)80.2%
Total4299£2 388 152 318555 513 (1 429 510)231 559 (114 619–487 063)3284
  • All investment reported in 2013 UK pounds.